Early drug formation

19 important questions on Early drug formation

What is the EU definition of the pharmaceutical development?

An activity that needs to be routinely carried out to establish that the type of dosage form selected and the formulation proposed are satisfactory for the purpose specified in the application. They also aim to identify those formulation and processing aspects that are crucial for batch reproducibility and which therefore need to be monitored routinely.

In a short way: Helps to better understand the nature/ design of the product
- gives a scientific overview of the product

What kind of information is gathered during the pharmaceutical development?

- characterization and finding studies( preformulation compatibility. composition)
- optimization (critical elements)
- verification studies 

Actually you show that you are able to produce the drug according to the requirements.

What are the key elements in the preformulation?

- The availability of a standard protocol
- Small scale tests
- Time to evaluate results
- Reporting of results and conclusion with a focus on future dosage from development
- Communication of results to people involved in further development
- Threads to preformulation: No regulatory requirements, Costs, time and capacity.
  • Higher grades + faster learning
  • Never study anything twice
  • 100% sure, 100% understanding
Discover Study Smart

What are the characteristics of the solution?

- pH solubility profile: max. solubility of pH 1-4
- pH stability profile: degradation above pH 5.5
-   effect of co-solvents
- sterilisation: no heat sterilisation possible

What are the characteristics of a solid?

- particle shape: cubic crystals
- specific surface area: 1,5 M2/g (large)
- flow properties: poor
- compaction: poor binding properties
- contact angle: 77 degrees
- intrinsic dissolution rate: 1.5 ug/cm2/min
- polymorphism: no
- No thermal explosion risk

What are the characteristics of the development of the first clinical formulation?

- based on results of the preformulation and the compatible studies
- It is a choice for a composition and a process based on limited experimental work.
- It is a combined activity of dosage form development and analytical development
- limits are: time, amount of drug substance, wide range of dosage strength.

Where does the development of the first clinical formulation rely on?

- standardisation
- experience with the dosage form, scientific knowledge on the dosage form
- downscaling (types of apparatus) and bracketing
- qualified and skilled personnel.
- good science from preformulation and compatibility

What is the target product profile?!

This is the most relevant starting document. (TPP). It means that a limited number of requirements must be established as reference in finding studies, focus on problems.

What are the specifications of the clinical capsule?

Things like loading capacity, degradation products, dissolution, powder flow,

What are prerequisites of a first clinical production?

- analytical methods must be validated
- cleaning must be proper
- Documentation

What are potential problems in the first clinical production?

- limited statistical information
-  changes in handling
- changes in equipment, scale and environment
- changes in dosage strength
- changes in drug substance

How is the prevention of problems?

- first production a joined activity of development and production (and analysis)
- Use formulations and technology with which experience exists and on which scientific knowledge is available
- clear and concise protocols and instructions
- adequate communication
- realistic setting of specifications and IPC's based on previous development work and previous experience with similar products and processes

When to start with the clinical studies with the market formulation?

- before central clinical studies: time is always limited, less analytical validation and stability work, no scale up and validation of the clinical form
- after central clinical studies: more time for development, more information available at the start, limited scale up and validation of the clinical form.

How is the market formulation developed?

- It is based on the clinical preformulation
- Develop analytical methods
- Use the PAR approve (The proven acceptable range)
- Work at laboratory scale
- Re-define your requirements

How do you optimize the formulation and the process?

- objectives: To find the optimal composition and the production process. To determine the clinical parameters (for validation)

Why a 10% production scale is necessary?

Authorities see a full production scale if a 10% production scale can be shown. An optimized and robust formulation and production process is necessary for this.

What kind of validation/qualifications are there?

- design of qualification
- installation qualification
- operational qualification (calibration
- process validation
- cleaning validation

How does the process validation flow-scheme go?

1) formulation and production process development.
2) optimisation to find critical parameters
3) scale up
4) write validation protocol
5) review and approval (here it can also become rejected)
6) execution
7) analysis, data acquisition
8) reporting
9) data review (by a qualified person)
10)acceptance or rejection (big problem)
11) change control and revalidation

What are the reasons to apply GMP during development?

- To survive regulatory inspections
- To improve R&D operations
- To ensure integrity of data
- To increase the change for regulatory sucess
- To ensure integrity of toxicological and clinical data
- to improve the quality of the production
- to reduce the overall costs.

The question on the page originate from the summary of the following study material:

  • A unique study and practice tool
  • Never study anything twice again
  • Get the grades you hope for
  • 100% sure, 100% understanding
Remember faster, study better. Scientifically proven.
Trustpilot Logo